Is KYNB or LBRX more undervalued in 2026?

CirclFi compares Kyntra Bio, Inc. (KYNB) and LB Pharmaceuticals Inc (LBRX) using 13 institutional-grade valuation models. KYNB has a Quality of Company score of 5.3/10 while LBRX scores 4.6/10.

Which is a better buy — KYNB or LBRX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do KYNB and LBRX valuations compare?

KYNB at $6.90 and LBRX at $27.97 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

KYNB vs LBRX Valuation Comparison 2026 — Intrinsic Value Analysis

KYNB

Pharmaceutical Preparations

Kyntra Bio, Inc.

Quality

5.3

out of 10

Value Trap

WARN

Price

$6.90

Last close

Models

7/13

Active

LBRX

Pharmaceutical Preparations

LB Pharmaceuticals Inc

Quality

4.6

out of 10

Value Trap

—

Price

$27.97

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	KYNB Fair Value	KYNB Upside	LBRX Fair Value	LBRX Upside
Bayesian DCF	Intrinsic	$16.17	+132.7%	$11.46	-59.0%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$16.33	+136.6%	$8.72	-68.8%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for KYNB vs LBRX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

KYNB vs LBRX — Which Stock Is More Undervalued?

KYNB scores higher with a 5.3/10 quality rating vs LBRX's 4.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Kyntra Bio, Inc. (KYNB) and LB Pharmaceuticals Inc (LBRX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

KYNB currently trades at $6.90 with a QOC of 5.3/10, while LBRX trades at $27.97 with a QOC of 4.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).